MTOR and melanoma: It has been previously demonstrated [6] that treatment of melanoma cells with mTOR inhibitors: rapamycin or everolimus had a significant effect on cell cycle regulation, and in consequence, proliferation [6, 8] as their use led to a significant reduction of the number of cancer cells.